GlassScriptPhysician profile
Ashish Agarwala
NPI 1982848156
$106,276.39
in general payments reported to CMS, 2019-2025
32 companies · $4,826 in 2025
The $4,826 reported for 2025 was more than what 90% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,771 · 2020: $4,698 · 2021: $64K · 2022: $2,934 · 2023: $25K · 2024: $3,478 · 2025: $4,826.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Education: $7,000 · Travel and Lodging: $3,427 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500 · Food and Beverage: $1,202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $19,100.00 |
| Education | $7,000.00 |
| Travel and Lodging | $3,427.04 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
| Food and Beverage | $1,202.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $102,123.54 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Boston Scientific Corporation | $1,158.99 | 2021-2024 | Apollo Esg System, Spyglass Discover |
| Tactile Systems Technology INC | $337.88 | 2020-2021 | |
| Ethicon US, LLC | $315.81 | 2019-2022 | |
| Baxter Healthcare | $260.04 | 2019-2023 | Tisseel |
| Exsomed Corporation | $248.03 | 2021-2022 | |
| Davol INC. | $234.09 | 2021-2025 | Phasix Mesh |
| Alafair Biosciences, INC. | $209.63 | 2021 | |
| Medtronic, INC. | $155.58 | 2021-2025 | Signia |
| Tela Bio, INC. | $125.20 | 2020-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| W. L. Gore & Associates, INC. | $119.90 | 2019-2025 | Gore Synecor Biomaterial |
| Covidien LP | $109.86 | 2019 | |
| Kci USA, INC. | $105.13 | 2022-2023 | V.A.C. Veraflo, Prevena |
| Cumberland Pharmaceuticals, INC. | $95.65 | 2020-2025 | Caldolor |
| Lilly USA, LLC | $78.06 | 2024-2025 | Zepbound |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $76.40 | 2019-2021 | |
| Teleflex LLC | $70.81 | 2019-2024 | Titan Sgs |
| Axonics, INC. | $69.79 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $62.56 | 2022-2024 | Gattex |
| Stryker Corporation | $59.14 | 2022 | |
| Redhill Biopharma INC. | $43.77 | 2020-2021 | |
| Acell, INC. | $42.15 | 2019 | |
| Integra Lifesciences Corporation | $21.71 | 2023 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Allergan, INC. | $19.23 | 2019 | |
| Avanos Medical | $18.97 | 2019 | |
| Activ Surgical, INC. | $18.65 | 2022 | |
| Vivus LLC | $18.54 | 2021 | |
| Nalpropion Pharmaceuticals LLC | $17.65 | 2019 | |
| Endo Pharmaceuticals INC. | $16.29 | 2019 | |
| Bard Access Systems, INC. | $16.29 | 2019 | |
| Currax Pharmaceuticals LLC | $14.89 | 2020 | |
| Medtronic USA, INC. | $12.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashish Agarwala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.